How can I be sure my fast health screening results are fair, before it's too late?

A 30-second video scan or a short remote questionnaire can now move an applicant from submission to decision in minutes, and that speed has quietly shifted the burden of proof. When a result arrives that fast, the applicant rarely sees what produced it, and the carrier rarely gets a second chance to explain it. Fairness in digital health screening insurance has become the question that sits underneath every accelerated underwriting program, and it is the question that chief medical officers and reinsurance medical directors are now expected to answer with evidence rather than assurance. The worry from the applicant side is simple: was the result accurate, and was it impartial? The obligation on the carrier side is more demanding, because regulators now treat an unexamined model as a compliance failure regardless of whether harm occurred.

A 2019 study published in Science by Ziad Obermeyer and colleagues at UC Berkeley found that a widely used health risk algorithm affecting roughly 200 million people in the United States systematically assigned lower risk scores to Black patients than to equally sick white patients, reducing the number of Black patients identified for extra care by more than half.

That finding did not involve insurance underwriting directly, but it reshaped how regulators think about every health-adjacent algorithm. It demonstrated that a model can be technically accurate on its primary objective and still produce disparate outcomes across protected groups, because the proxy it optimized for carried embedded inequity. For a carrier deploying contactless vitals or rapid screening, the lesson is that accuracy and fairness are separate properties that require separate testing.

Why fairness in digital health screening insurance is now a filing requirement

Fairness in digital health screening insurance is no longer a values statement that lives in a corporate ethics charter. It is a documentable control that examiners expect to see. The NAIC Model Bulletin on the Use of Artificial Intelligence Systems by Insurers, adopted in December 2023 and since adopted by a growing number of states, requires insurers to maintain a written AI Systems Program built on transparency, fairness, and accountability. The bulletin is principle-based rather than prescriptive, which means it does not hand carriers a test to run. It instead holds them responsible for proving they identified and controlled for errors, bias, and potential unfair discrimination across the full model lifecycle.

This matters because the consumer-facing anxiety and the regulatory standard converge on the same evidence. An applicant asking whether a screening was fair is asking the same thing a market conduct examiner asks: can you show, with data, that the result a person received was not influenced by a protected characteristic or a proxy for one. The difference is that the applicant asks after a denial, while the regulator asks during an exam. A carrier that can only answer one of those questions is exposed on the other.

The fairness obligation also extends to vendor-supplied models. The NAIC bulletin expects carriers to retain audit rights over third-party systems and to cooperate with regulatory inquiry even when the underlying model was built elsewhere. A medical director cannot delegate accountability to a vendor's documentation that the carrier has never independently reviewed.

Dimension	Traditional medical exam	Unmanaged digital screening	Compliance-ready digital screening
Decision speed	Days to weeks	Seconds to minutes	Seconds to minutes
Bias testing	Implicit, clinician-dependent	None or undocumented	Documented across protected classes
Auditability	Paper file, hard to query	Black box, limited logging	Versioned model logs and decision trail
Regulatory posture	Established precedent	High examination risk	Aligned to NAIC AI bulletin
Applicant recourse	Request reexamination	Often unclear	Defined adverse action and review path
Proxy discrimination risk	Low but variable	High and unmeasured	Measured and mitigated

The anatomy of an unfair result

Unfairness in a rapid screening rarely comes from explicit use of a protected attribute. It enters through quieter channels that a governance program has to actively hunt for.

• Training data imbalance, where a model learned from a population that underrepresents certain ages, skin tones, or body types, producing weaker accuracy for those groups.
• Proxy variables, where a seemingly neutral input correlates with a protected characteristic and reproduces its effect.
• Measurement error in the signal itself, such as optical heart-rate estimation performing differently across skin pigmentation under varied lighting.
• Threshold effects, where a single cutoff applied uniformly produces disparate referral rates across subgroups.
• Feedback loops, where past underwriting decisions become training labels and harden historical bias into future predictions.

Each of these failure modes is detectable, but only if a carrier defines the protected groups it will measure against, sets fairness metrics in advance, and tests before deployment rather than after a complaint.

Industry applications and where the risk concentrates

Accelerated life underwriting

Accelerated programs use digital screening to waive fluids and exams for qualifying applicants. The fairness exposure here is twofold: who gets offered the accelerated path, and what happens to those routed to traditional underwriting. If subgroup membership predicts the route, the program can create disparate access even when the final mortality assessment is sound. Underwriting technology standards increasingly expect carriers to monitor referral rates by demographic segment, not only final decision outcomes.

Reinsurance treaty oversight

Reinsurance medical directors inherit the fairness risk of every ceding carrier's screening tool. Treaty language has begun to specify model governance expectations, audit access, and bias-testing evidence as conditions of coverage. A reinsurer that accepts business underwritten by an untested model assumes both the mortality risk and the regulatory tail risk of that model's potential discrimination.

Simplified issue and final expense

These products often serve populations that are older or have prior health conditions, which raises the stakes for screening accuracy across exactly the groups where digital tools have historically shown the widest performance gaps. Digital underwriting compliance in these segments depends on demonstrating that the tool performs comparably across the applicant base it actually serves.

Current research and evidence

The academic record now supports treating fairness as a measurable engineering property. A 2023 systematic review of algorithmic bias in insurance underwriting published in the journal Information (MDPI) cataloged how bias enters underwriting models through data, design, and deployment, and emphasized that fairness must be defined operationally because different fairness metrics can conflict with one another. Reviews of algorithmic bias in healthcare, including work indexed in the National Library of Medicine, reach a parallel conclusion: representative data and explainability are necessary but not sufficient, and ongoing monitoring after deployment is where most programs fall short.

The Obermeyer findings remain the clearest demonstration that a high-performing model can still be unfair, because the harm came from the choice of optimization target rather than from a coding error. For insurance specifically, the regulatory translation is direct. The NAIC bulletin's expectation that carriers verify and test for unfair discrimination mirrors what the research says is required: pre-specified protected groups, multiple fairness metrics, documented thresholds, and a monitoring cadence that catches drift after launch. Evidence of a single pre-deployment test is not the same as evidence of a control that operates continuously.

What the literature does not provide is a single agreed definition of fairness, and carriers should not wait for one. Demographic parity, equalized odds, and calibration can pull in different directions, so the defensible posture is to choose metrics deliberately, document why, and show the tradeoffs were considered rather than ignored.

The future of fairness in digital health screening

The direction of travel is toward continuous, auditable fairness rather than point-in-time certification. Several shifts are already visible. State adoption of the NAIC bulletin is expanding the number of jurisdictions where a written AI program is effectively mandatory, which pushes fairness testing from optional to baseline. Examination practice is moving toward requesting model documentation, version histories, and subgroup performance data during market conduct reviews, which raises the cost of undocumented programs. Reinsurance treaties are encoding governance expectations, which extends fairness obligations across the value chain rather than leaving them with the originating carrier.

The practical consequence for medical leadership is that fairness becomes part of the operating model, not a project. Carriers that build subgroup monitoring, adverse action transparency, and vendor audit rights into the system from the start will spend less than those forced to retrofit them under examination pressure. The applicant question and the regulator question are converging, and the carriers that can answer both with the same evidence file will hold a durable advantage.

Frequently asked questions

What does fairness mean in the context of a digital health screening for insurance? It means the screening produces accurate results across demographic groups and does not let a protected characteristic, or a proxy for one, influence the outcome. Fairness is distinct from accuracy, because a model can be accurate overall and still produce disparate results for specific subgroups, so it has to be tested separately and documented.

Does the NAIC AI Model Bulletin require carriers to test for bias? The bulletin, adopted in December 2023 and now used by a growing list of states, requires a written AI Systems Program built on transparency, fairness, and accountability, and it expects insurers to use verification and testing methods to identify errors, bias, and potential unfair discrimination. It is principle-based, so it holds carriers accountable for the outcome rather than prescribing a specific test.

Who is responsible when a third-party screening model produces an unfair result? The carrier remains accountable. Regulatory guidance expects insurers to retain audit rights over vendor models and to cooperate with regulatory inquiries regardless of who built the system, so a medical director cannot transfer fairness accountability to a vendor's documentation alone.

How can an applicant challenge a screening result they believe is unfair? A compliance-ready program defines an adverse action and review path, which gives applicants a route to request human review or reexamination. The presence of that defined recourse is also part of what examiners look for when assessing whether a digital program treats consumers fairly.

Circadify is building toward this convergence of consumer fairness and regulatory evidence, helping carriers and reinsurers document digital underwriting controls that hold up under examination. For compliance guides and regulatory insights tailored to medical and underwriting leadership, visit circadify.com/industries/payers-insurance.